Antineoplaston Therapy in Treating Patients With Soft Tissue Sarcoma

NCT00003521 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped slow accrual

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute